摘要
With the prevalence of novel strains and drug-resistant influenza viruses, there is an urgent need to develop effective and low-toxicity anti-influenza therapeutics. Regulation of the type I interferon antiviral response is considered an attractive therapeutic strategy for viral infection. Pterostilbene, a 3,5dimethoxy analog of resveratrol, is known for its remarkable pharmacological activity. Here, we found that pterostilbene effectively inhibited influenza A virus infection and mainly affected the late stages of viral replication. A mechanistic study showed that the antiviral activity of pterostilbene might promote the induction of antiviral type I interferon and expression of its downstream interferon-stimulated genes during viral infection. The same effect of pterostilbene was also observed in the condition of polyinosinic-polycytidylic acid (poly I:C) transfection. Further study showed that pterostilbene interacted with influenza non-structural 1 (NS1) protein, inhibited ubiquitination mediated degradation of RIG-I and activated the downstream antiviral pathway, orchestrating an antiviral state against influenza virus in the cell. Taken together, pterostilbene could be a promising anti-influenza agent for future antiviral drug exploitation and compounds with similar structures may provide new options for the development of novel inhibitors against influenza A virus (IAV).
学科与关键词
- Multiple modes of action of myricetin in influenza A virus infectionSang, Huiting; Huang, Yingna; Tian, Yuanxin; Liu, Miaomiao; Chen, Liurong; Li, Lin; Liu, Shuwen; Yang, Jie*Phytotherapy Research, 2021, 35(5): 2797-2806.被引 12
- Phenolic compound SG-1 from Balanophora harlandii and its derivatives exert anti-influenza A virus activity via activation of the Nrf2/ HO-1 pathwayZhou, Runhong; Hu, Jianan; Qiu, Jingnan; Lu, Shengsheng; Lin, Haixing; Huang, Ruifeng; Zhou, Shaofen; Huang, Guoqing; He, Jian*Biochemical Pharmacology, 2023, 210: 115495.
- MicroRNA let-7 Suppresses Influenza A Virus Infection by Targeting RPS16 and Enhancing Type I Interferon ResponseWu, Wenjiao; Wang, Chao; Xia, Changliang; Liu, Shuwen*; Mei, Qinghua*Frontiers in Cellular and Infection Microbiology, 2022, 12: 904775.被引 3
